Pricing Log in Create free account
Friday 6 November 2026 Export RPRX’s income statement to Excel — free account

Royalty Pharma PLC

RPRX Healthcare Biotechnology

Royalty Pharma PLC’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 5.06% from fiscal 2024.

Revenue
+13.3%
EPS
−51.5%
Free cash flow
+364.6%
Total debt
−4.00%

Quarter to September 2026, against a year earlier

67.13 0.44 −0.65%
Market cap
$39.0B
P/E
44.8×
Fwd P/E
27.3×
Dividend yield
1.37%
F-score
5/9
Altman Z
1.61
Beneish M
−2.83
Dividend safety
41/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Royalty Pharma PLC (RPRX) EBITDA

Alert me on EBITDA

Royalty Pharma PLC's EBITDA for fiscal 2025 was $1.6B, up 21.3% from $1.3B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.5B. Over the past ten years it has ranged from $334.1M (fiscal 2022) to $2.7B (fiscal 2019); the current reading is higher than 75% of that period. Royalty Pharma PLC ranks 4th of 594 Biotechnology companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $1.6B 21.34%
FY2024 $1.3B (13.26%)
FY2023 $1.5B 352.77%
FY2022 $334.1M (77.33%)
FY2021 $1.5B (9.59%)
FY2020 $1.6B (38.71%)
FY2019 $2.7B 88.53%
FY2018 $1.4B —

Quarterly newest first

Period EBITDA Change
Jun 2026 $142.1M (75.14%)
Mar 2026 $571.9M 44.01%
Dec 2025 $397.1M (8.98%)
Sep 2025 $436.3M 99.08%
24 more quarters

Against its own ten years

Low $334.1M High $2.7B
Ten-year median $1.5B
Current reading's percentile 75

EBITDA against peers

Company EBITDA
ARGX argenex SE compare $1.7B
RPRX Royalty Pharma PLC $1.5B
ONC BeOne Medicines Ltd. - Sponsored ADR compare $1.4B
GMAB Genmab A/S Sponsored ADR compare $1.2B
INCY Incyte Corporation compare $724.9M
INSM Insmed, Inc. compare −$531.4M
ROIV Roivant Sciences Ltd. compare −$593.3M
BNTX BioNTech SE Sponsored ADR compare −$1.1B
RVMD Revolution Medicines, Inc. compare −$1.6B

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on RPRX